Dermatology
Latest News
‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib Trials
“This is the longest safety study ever published for any systemic drug for AD,” Christopher G. Bunick, MD, said.
Latest News
‘Real-World’ Registry Study of Upadacitinib Supports Clinical Trial Data
“We know from clinical trials that upadacitinib is effective, but we have very little real-world experience on its effectiveness,”...
Latest News
What Makes Patients Vulnerable to Delusions of Parasitosis?
"Changes in health care, such as the dramatic increase in stimulant prescriptions and alternatives to opioids in pain management, may be...
Latest News
FDA Approves Topical Gel For Wounds Associated With JEB and DEB
The FDA has approved a topical gel containing birch triterpenes for the treatment of partial thickness wounds in patients 6 months and older with...
Latest News
Paradoxical Eczema Risk Low With Biologic Psoriasis Treatments
The study included data for all currently available biologics, “originating from more than 160 dermatology centers in the UK and Ireland,” the...
Feature
How to Reduce Cardiovascular Morbidity and Mortality in Psoriasis and PsA
Experts take a look at the landscape of why and how dermatologists and rheumatologists ought to play a more consistent and active role in primary...
Latest News
Roflumilast foam gets nod as new option for seborrheic dermatitis
The approval was based on data from the phase 3 STRATUM trial...
Opinion
A 55-year-old female presented a with few years' history of pruritic plaques on her shins and wrists
A woman presents with thick, pruritic, erythematous plaques on her shins and wrists that come and go.
Latest News
How does lebrikizumab perform across different racial and ethnic subgroups?
Prior use of systemic therapy was lower in the Black and “other” subgroups, compared with other racial subgroups.
Latest News
Pilot study educates barbers about pseudofolliculitis barbae
Barbers received questionnaires before and after participating in a session that involved a review of a comprehensive educational brochure with...
Latest News
GVHD raises vitiligo risk in transplant recipients
Graft-versus-host disease appears to raise vitiligo risk in transplant recipients, particularly those who receive hematopoietic stem cell...